KATHLEEN ROSE BECK
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAINT CLAIR SHORES, MI NPI 1790168136
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MI AIMMUNE THERAPEUTICS, INC. All categories
General Payments — all program years on this page
$281.48
- Category: General Payments
- Program years: PY2024
- Record count: 6
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $281.48 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $197.48 | 5 |
| Education | $84.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $116.97 | 1 |
| Janssen Biotech, Inc. | $84.00 | 1 |
| ABBVIE INC. | $34.64 | 2 |
| GENZYME CORPORATION | $25.17 | 1 |
| Lilly USA, LLC | $20.70 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $281.48 | 6 |
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078763032 | Janssen Biotech, Inc. | $84.00 | 07/30/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1106502489 | ABBVIE INC. | $17.36 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106502491 | ABBVIE INC. | $17.28 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135729137 | Lilly USA, LLC | $20.70 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139932943 | GENZYME CORPORATION | $25.17 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146972091 | AIMMUNE THERAPEUTICS, INC. | $116.97 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.